Reported Late Monday, ZyVersa Therapeutics Inc. And Larkspur Health Acquisition Corp. Close Business Combination; ZyVersa Expected To Begin Trading On Nasdaq December 13, 2022 Under Ticker “ZVSA”
ZyVersa is a clinical stage biopharmaceutical company developing first-in-class product candidates for treatment of renal and inflammatory diseases
WESTON, Fla. and BRIDGEWATER, N.J., Dec. 12,
